October 21, 2025 · Form 4 insider transaction
Lazar David E. bought 6,388,000 shares of NBY, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 100 days after the transaction.
The shares of Common Stock reported herein were issued upon the automatic conversion of the Series D Preferred Stock held by the Reporting Person three business days after the annual meeting of stockholders (the "Annual Meeting") of NovaBay Pharmaceuticals, Inc. (the "Issuer"), which occurred on October 16, 2025.